Abin da Taswirar Rufewar HDX-MS A Haƙiƙa Yayi Rahoton
A cikin ƙasa-up HDX-MS aiki gudana, Ana narkar da furotin ko hadaddun da aka lakafta - yawanci ta hanyar pepsin mara motsi - kuma ana raba peptides da aka samu ta hanyar chromatography na ruwa kuma ana gano su ta hanyar yawan gani.. Kowane peptide proteolytic yana ɗaukar ƙimar deuterium-uptake a kowane lokacin alamar alama. Tarin waɗannan peptides da aka gano a cikin cikakken jerin ana kiran taswirar ɗaukar hoto (wani lokacin taswirar peptide).
Taswirar ɗaukar hoto tana amsa takamaiman tambayoyi guda biyu. Na farko, Waɗanne yankuna na jerin da aka yi samfurin a zahiri? Na biyu, nawa matsowa, peptides da aka ba da tabbaci suna goyan bayan kowane sashi? Kamar yadda aka taƙaita a cikin Bayanan Bayani na HDX-MS, Yankunan da aka rufe da yawancin peptides masu haɗuwa suna ba da ƙarfi, ingantaccen wurin karantawa, yayin da keɓaɓɓen ko ba a rufe shi ba yana ba da gudummawar bayanai game da musayar.
Peptide Synthesis The Hanyoyin Halitta HDX-MS jagora yana ba da shawarwari da yawa waɗanda ke ɗaukar ɗaukar hoto azaman kashin baya na tauri: bayar da rahoton ɗaukar hoto, samar da filayen ɗaukar kowane-peptide tare da daidaitattun karkatattun su, da gudanar da kima mai inganci (denaturing gel, m taro, kuma, inda ya dace, girman-kebe ko na asali MS) kafin a fara lakabi. Yankuna shiru na furotin suna da sauƙin mantawa yayin fassara taswirar bambanci, amma taswirar ɗaukar hoto yana tilasta su a gani.
Yadda Taswirorin Rubutun Ke Fasa Tsari da Ƙarshen Ma'amala
Ƙarfin fassarar HDX-MS a cikin nazarin TCR-peptide-HLA shine yana juya jerin canje-canjen ɗauka zuwa taswirar ɗaure mai ma'ana - muddin ɗaukar hoto ya goyi bayan ƙaddamarwa.. Ba za a iya karanta yankin da ba a rufe da kyau a matsayin "ba a canzawa"; shi ne kawai ba a sani ba. Taswirorin ɗaukar hoto suna yin waɗancan iyakoki a sarari don haka mai bincike ba zai wuce fassarar rashi sigina azaman rashin canjin tsari ba..
Peptides na roba src = "https://molchanges.com/wp-content/uploads/2026/09/pub_20260904_102802_361_a6c5a1d6f08a493c9f4d3cc4fc9a3767.png">
Daidai mahimmanci, Taswirorin ɗaukar hoto suna taimakawa rabuwa kai tsaye kariya kariya daga kaikaice, canji na allosteric. HDX-MS yana ba da rahoto mai ƙarfi, bayanin matakin peptide maimakon atomistic daki-daki. Lokacin da wani yanki da aka karewa akan hadadden tsari ya lalace ta hanyar peptides masu yawa, Ƙarshen cewa yana zaune a haɗin haɗin kai ya fi karewa. Lokacin da kariya ta bayyana a cikin yanki mai nisa daga saman tuntuɓar da ake tsammani, rufaffiyar ɗaukar hoto yana ba mai bincike damar yin gardama don samun ingantaccen martani mai tsayi mai tsayi maimakon ƙaƙƙarfan samfuri..
Wannan bambance-bambancen yana da mahimmanci a cikin ilimin halitta. Yankin da ya keɓe kan haɗin gwiwar abokin tarayya na iya yin nuni da ainihin canji mai daidaituwa, yayin da yankin da ba a rufe kwata-kwata zai bayyana shiru cikin taswirar bambanci kuma yana iya ɓatar da fassarar samfurin docking shiru..
Abin da Taswirorin Rubutu ke Bayyana Game da Haɗin TCR da Yanayin ɗaure
TCRs sun gane gajerun peptides wanda HLA ya gabatar, kuma ma'auni na wannan haɗin gwiwa shine babban tambaya a ilimin rigakafi. Docking na canonical yana sanya TCR a diagonal a fadin tsagi mai ɗaure peptide: madaukakan CDR1 da CDR2 suna tuntuɓar saman MHC α-helices, yayin da madaukai masu sassauƙa na CDR3 da farko suna ɗaukar peptide da aka gabatar da kanta. A 2024 Frontiers suna nazarin ƙididdige TCR:pMHC-I canjin yanayi yana ƙarfafa wannan hoton: CDR3α ya mamaye lambobin sadarwa tare da rabin N-terminal na peptides marasa suna da CDR3β rabin C-terminal, kuma peptides suna daga cikin abubuwan da suka fi dacewa da wayoyin hannu na hadaddun.
Peptide-matakin HDX-MS na al'ada na iya ci gaba da bambanta TCRs waɗanda ke haɗa pHLA ɗin su da kyau daga waɗanda ba sa - har ma da bambanta sawun ɗauri., gami da canonical sabanin docking ɗin da ba na canonical ba da kuma mai da hankali kan tsaka-tsaki tare da daidaita lambobin TCR. A aikace, bambance-bambancen deuterium a fadin CDR da aka rufe da kyau da yankuna α-helix yana bayyana inda kariyar ke maida hankali lokacin da aka ba da TCR., ƙyale masu bincike su kwatanta yadda daban-daban TCRs ko bambance-bambancen amsawa ga manufa pHLA iri ɗaya.
An Nazarin HDX-MS na bambance-bambancen TCR masu haɓaka alaƙa (wanda aka yi niyya SONG-A*0201 yana gabatar da NY-ESO-1) yana kwatanta zurfin samuwa: pMHC dauri galibi ya canza kariyar TCR CDR, kuma mutantan β-CDR3 guda ɗaya ya samar da sa hannun bimodal EX1 daidai da jinkirin jawo-daidaita yanayin ɗaure maimakon madaidaicin ma'amala-da-maɓalli.. Waɗannan ƙaddamarwa suna ɗaukar nauyi ne kawai lokacin da madaukai na CDR, peptide, kuma MHC α-helices suna zaune a cikin amintaccen rufin asiri, rufaffiyar sassan peptide.
Me yasa Peptide Reagent Ya Kasance Sashe na Tambayar Tsarin
Kayan peptide baya mamaye tsagi kawai; yana daidaita tsarin. Tsarin-tsari-tsari yana nuna ɗorawa peptide yana siffanta halayen halayen HLA, kuma ana tuntuɓar peptide ta wayar hannu kai tsaye ta madaukai na TCR CDR3. Wannan yana nufin ainihin mahallin sinadarai wanda aka ɗora a cikin HLA shine abin da HDX-MS ke tambaya - kuma jerin sa da ingancin sa kai tsaye ke ƙayyade karatun..
Wannan shine inda ƙirar peptide da abubuwan da ke kewaye da ilimin halitta suka haɗu. Ko jerin suna ɗaure da aka ba HLA allele ya dogara da ragowar anka da kuma abubuwan ɗaure.. peptide wanda baya mamaye tsagi ba zai iya samar da hadaddun ternary wanda binciken yayi niyyar aunawa.. Don haka ƙira ta yanke shawarar wane hadaddun haƙiƙanin wanzuwa a cikin gwajin lakabin.
Ikon gyarawa daidai yake ba zai iya rabuwa ba. Bincike akan peptides na roba tare da gyare-gyaren sinadarai marasa hankali yana nuna cewa gyare-gyaren da ba zato ba tsammani na iya aiki ta hanyar kwaikwayar kwayoyin halitta, ba da gangan kunna T-cell clones tare da ba zato ba tsammani, ƙayyadaddun abubuwa masu yuwuwar amsawa ta atomatik. Ko da ƙaramin canjin da ba a yi niyya ba zai iya haifar da sabon epitope ko canza ƙimar TCR - ma'ana sawun tsarin da aka auna na iya kasancewa na nau'in ban da wanda aka tsara..
Abubuwa huɗu masu alaƙa don yin la'akari tare a cikin Ayyukan Ayyukan Immunology
A cikin binciken peptide da HLA, babu ma'aunin QC guda ɗaya da ke tsaye shi kaɗai. Dole ne a kula da abubuwa huɗu azaman tsarin haɗin gwiwa, saboda rauni a cikin kowane mutum na iya lalata wani gwaji na hankali.
Tsarin Peptide saita antigen da aka nufa: dalili, anka matsayi, da tsayin da ke ƙayyade ɗaurin HLA da gabatarwa. Kyakkyawan tsari amma jeri mara kyau na ilimin halitta yana bata gwajin.
Ikon gyarawa yana tabbatar da cewa peptide yana ɗaukar ainihin gyare-gyaren da aka yi niyya - kuma babu wanda ba a yi niyya ba. Saboda nau'ikan da aka gyara na iya zama mai ƙarfi, Chemistry gyare-gyaren da ba a sarrafa shi tushe ne na kayan tarihi na shiru a cikin wayar salula da karatun HDX-MS.
Tsafta yana bayyana juzu'in samfurin wanda shine madaidaicin jerin manufa. Roba peptides tara truncations, jerin sharewa, da samfuran gefe, kuma binciken rashin tsarki na peptide a cikin gwajin rigakafin ya nuna cewa hanyoyin QC na yau da kullun na iya rasa peptides masu gurbata giciye masu ƙarfi ta halitta. Lokacin da ƙwayoyin T ke amsawa a ƙididdiga masu yawa, ko lokacin da ma'auni mai ma'ana yana kallon taswirar peptide, ƙazanta na iya zama kamar sigina ko kashe shi.
Halayen nazari yana rufe madauki. A matsayin jagorar fasaha akan bambanta tsaftar peptide daga abun ciki damuwa, Juya-lokaci na HPLC tsafta yana ba da rahoton babban yanki-ƙololuwar yanki amma baya ƙidaya ruwa, gishiri, ko counterions zaune a cikin vial. Mass spectrometry yana tabbatar da ainihi amma yana iya rasa haɗin gwiwar gurɓataccen giciye. Abubuwan da ke cikin peptide ta hanyar nazarin amino acid yana ba da ainihin adadin da za a iya amfani da shi, da kuma kula da counterion (misali canza trifluoroacetate zuwa acetate) al'amura a duk inda nau'in ionic zai iya tsoma baki tare da karatun MS.
Kowane ɗayan waɗannan abubuwa huɗu yana amsa ɗaya daga cikin tambayoyin guda uku: Shin peptide daidai ne? Shin yana da daidaito ta hanyar sinadarai? Shin yana da tsarki sosai cewa abin karantawa yana nuna antigen da aka yi niyya maimakon kayan tarihi? Babu wani zaɓi, kuma tare suna tantance ko taswirar ɗaukar hoto na HDX-MS ta kwatanta hadaddun da aka ƙera ko wanda ba a yi niyya ba.
Lissafin Mahimmanci na QC don HDX-MS da HLA-Binding Work
Don peptide da aka yi niyya don ciyarwa cikin aikin HDX-MS ko TCR-peptide-HLA, Nemi fakitin nazari wanda yayi daidai da azancin kima na ƙasa maimakon takardar shedar gama gari.
-
Tabbatar da jerin da ake sa ran ta daidaitaccen taro da, inda ake buƙatar tabbacin matakin-jeri, ta MS/MS peptide taswira.
-
Tabbatar da tsabtar HPLC akan ≥95%, kuma sun fi son ≥98% don ƙididdigewa ko ƙazanta-tsara-tsari da aikin ɗaure..
-
Nemi abun ciki na peptide ta hanyar nazarin amino acid don haka an san adadin peptide daidai, ba kawai juzu'i mafi girma na chromatographic ba. Samuwar Peptide
-
Ƙayyade kuma tabbatar da nau'in ƙiyayya, musamman lokacin da trifluoroacetate zai iya tsoma baki tare da ionization ko karatun ionic.
-
Tabbatar da gyare-gyaren da aka yi niyya kuma bincika waɗanda ba a yi niyya ba, musamman ma a raƙuman amsawa ko lokacin da peptide ke ɗaukar wuraren gyara biyu ko fiye.
-
Nemi takamaiman bayanai na ƙididdiga da kwatanta tsabta, abun ciki, da bayanan ƙazanta a cikin batches kafin yin oda mai yawa na dogon nazari.
ƙwararrun masu samar da kayayyaki suna gina waɗannan a cikin tsarin aiki. A al'ada peptide kira dandamali wanda ke ba da ƙayyadaddun matakan tsafta har zuwa 99%, peptides mai labeled isootope don ma'auni na ciki a cikin tsarin-ma'amala MS, kuma an rubuta gwajin peptide da halayen nazari - juyawa-lokaci HPLC, Mass spectrometry, amino acid analysis, musayar musayar yawu, da sarrafawar haifuwa - yana ba da aikin tsari yadda ake gano abin da yake buƙata a sama na kayan aikin HDX-MS.
Don Tukwici: Lokacin da kuka yi odar analogs peptide da yawa don kwamitin TCR-peptide-HLA, kwatanta ba kawai adadin tsaftar da ake da'awarsu ba amma bayanan ƙazantansu da abun ciki na peptide gefe da gefe. peptides guda biyu tare da tsaftar ƙima iri ɗaya na iya isar da nau'ikan kayan da ake amfani da su daban-daban - da kuma yanayin ɗauri daban-daban..
Rufewa da Sarrafa Hannu biyu ne na Dogaran HDX-MS
Nazarin HDX-MS na hadaddun TCR-peptide-HLA amintacce ne kawai kamar taswirar ɗaukar hoto da reagent ɗin sa.. Rufewa yana ƙayyade inda fasaha za ta iya magana da amincewa; peptide zane, sarrafa gyarawa, tsarki, kuma siffa ta nazari ta ƙayyade cewa hadaddun da ake bincikar shine wanda mai gwaji ya nufa. Ɗauke su azaman tsari ɗaya maimakon wuraren bincike daban, kuma fassarar tsarin yana samun ƙarfin da filin ke tsammani.
Idan ƙungiyar ku tana ƙirar peptides ko HLA ligands don tsarin tsari da karatun ɗaure kuma suna son tattauna matakan tsafta., gyare-gyaren sunadarai, ko bayanan nazari a bayan tsari, MOL Canje-canje ƙwararrun peptide za su iya yin bitar takardun shaida da buƙatun QC don takamaiman aikin ku.
